Nephrotic syndrome complicating alpha-interferon therapy;Syndrome nephrotique compliquant un traitement par interferon alpha

Presse Medicale

Volumn 25, Issue 23, 1996, Pages 1066-1068

  Dhib, M ^a,d   Bakhache, E ^b   Postec, E ^c   Vanrenterghem, B ^b   Le Roy, F ^a   Azar, R ^b   Francois A ^a   Boldron, A ^b   Amaria, R ^c   Ozenne, G ^a   Hermelin, A ^c  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b Service de Néphrologie   (France)

^c LE HAVRE HOSPITAL   (France)

^d Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; RECOMBINANT ALPHA2A INTERFERON; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CASE REPORT; HUMAN; LYMPH NODE METASTASIS; MALE; MELANOMA; NEPHROTIC SYNDROME; PERTHES DISEASE; ACUTE KIDNEY FAILURE; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; REVIEW;

ANTINEOPLASTIC AGENTS; HUMANS; INTERFERON-ALPHA; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; NEPHROTIC SYNDROME;

EID: 0030605709     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hory B, Saunier F, Wolff R, Saint-Hilher Y, Coulon G, Perol C Waldenström macroglobulinemia and nephrotic syndrome with minimal change lesion. Nephron 1987; 45 68-70.
2. Jones GJ, Itri LM Safety and tolerance of recombinant interferon alpha-2a (Roferon A) in cancer patients. Cancer 1986; 57:1709-13.
3. Quesada JR, Talpaz M, Riso A, Kurzrock R, Gutterman JU Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol 1986, 4:234-43.
4. Weiss KS. Nephrotic range of proteinuria and interferon therapy. Ann Intern Med 1992; 116-347.
5. Herrman J, Gabriel F Membranoproliferative glomerulonephrus in a patient with hairy cell leukemia treated with alpha-II interferon. N Engl J Med 1987; 316:112.
6. Sclby P, Kohn J, Raymond J, Judson I, Mc Elwain T. Nephrotic syndrome during treatment with interferon Br Med J 1985; 290.1180.
7. Averbuch SD, Austin HA, Sherwin SA, Antonovych T, Bunn PA, Longo DL Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte A interferon therapy for mycosis fungoides. N Engl J Med 1984, 310 32-5
8. Traynor A, Kuzel T, Samuelson E, Kanwar Y. Minimal-change glomerulopathy and glomerular visceral epithelial hyperplasia associated with alpha-interferon therapy for cutaneous T-cell lymphoma Nephron 1994, 67 94-100.
9. Natr S, Ernstoff MS, Bahnson RR et al. Interferon-induced reversible acute renal failure with nephrotic syndrome, Urology 1992; 39 169-72.
10. Fahal IH, Murry N, Chu P, Bell GM. Acute renal failure during interferon treatment. Br Med J 1993; 306:973.
11. Ault BH, Bruder-Stapleton F, Gaber L, Martin A, Roy S, Murphy SB. Acute renal failure during therapy with recombinant human gamma interferon N Engl J Med 1988, 319:1397-400.
12. Lederer E, Truong L, Unusual glomerular lesion in a patient receiving long-term interferon alpha Am J Kidney Dis 1992; 20:516-18.
13. Moss J, Shore I, Woodrow D, Gresser I. Interferon-induced glomerular basement membrane and endothelial cell lesions in mice. An immunogold ultrastructural study of basement membrane components. Am J Pathol 1988; 133:557-63.
14. Miranda-Guardiola F, Fdez-Llama P, Badia JR et al. Acute renal failure associated with alpha-interferon therapy for chronic hepatitis B. Nephrol Dial Transplant 1995; 10:1441-3.
15. Parker MG, Atkins MB, Ucci AA, Levey AS. Rapidly progressive glomeruloneprius after immunotherapy for cancer J Am Soc Nephrol 1995; 5:1740-4
16. Jadoul M, Piessevaux H, Ferrant A, Cosyns JP, Van Ypersele de Strihou C. Renal thrombotic microangiopathy in patients with chronic myelogenous leukaemia treated with interferon-alpha 2b Nephrol Dial Transplant 1995; 10:111-13.
17. Stratta P, Canavese C, Doghani M et al Hemolytic-uremic syndrome during recombinant alpha-interferon treatment for harry cell leukemia Renal Failure 1993; 15:559-61.
18. Kurschel E, Metz-Kurschel U, Niederle N, Aulbert E Investigations on the subclinical and clinical nephrotoxicity of interferon-alpha 2b in patients with myeloproliferative syndromes Renal Failure 1991; 13:87-93.